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   conclusions
.  genetic testing context in new Zealand
It is not surprising that New Zealand’s primary health-care practitioners (and other 
non-geneticists) feel unprepared to deal with the existing requests and expected 
increased demand for genetic testing given the absence of a national policy or strategy 
for genetics services delivery, or any guidelines for referral for testing or follow-up 
post testing. Genetics services in New Zealand appear to suffer from a lack of co-
ordination and resourcing. Such disorder cannot facilitate the necessary education 
and guidance required by GPs, paediatricians and other health professionals. 
It is vital that GPs and other health professionals know more about genetic testing 
and genetics services in New Zealand, so that they can better facilitate informed 
consent; recognise and acknowledge any limitations in their expertise, particularly as 
they will influence their patients when they discuss testing possibilities;1 know when 
to refer patients for genetic testing; and offer some degree of genetic counselling, if 
required. 
Additionally, there is some concern that, as genetic testing becomes increasingly 
ubiquitous in New Zealand, and is increasingly dealt with by primary health-care 
professionals, genetic counselling will be inadequate or non-existent (because of 
training, time and resource deficits). 
.2  Does genetic testing of minors raise different issues from those involved in  
 other medical decision-making contexts?
The issue of genetic testing of minors is far from uncontroversial. Genetic testing of 
minors does raise new issues from those involved in other medical decision-making 
contexts. Most of the concerns relevant to minors in particular are prompted by the 
familial and predictive aspects of genetic information. Genetic testing may have far 
greater personal implications for other family members than decisions made in other 
medical contexts. Additionally genetic information has the power to be more predictive 
of future health than other medical tests or interventions, which has implications for 
the minor’s best interests and autonomy. The limited ability of genetic information 
to predict outcomes is also a source of concern: genetic information can be difficult 
to understand and its implications easily misunderstood.
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.  Professional guidelines and position papers in respect of genetic testing  
 of minors
1.3.1  Minors who cannot give informed consent
The position statements and guidelines reviewed earlier, and those reviewed by 
Borry et al., take a generally prohibitive stance towards genetic testing of minors 
(who cannot give their own informed consent) for untreatable late-onset disorders. 
Medical benefits comprise the main justification recognised for any genetic testing of 
children, although special circumstances in which testing may result in other greater 
psycho-social benefits (as opposed to harms) are considered. There is some ambiguity 
about the approach to be taken to parental requests for genetic testing for early onset 
conditions for which no prevention or treatment is available. There appears to be 
less consensus and certainly fewer recommendations in respect of carrier testing of 
minors. Those that exist appear to take a slightly more lenient view of such testing 
than they do of predictive testing for untreatable late-onset disorders.
1.3.2  Competent minors
The HGSA Guidelines on Predictive	Testing	in	Children	and	Adolescents would allow 
competent minors in New Zealand to give informed consent to predictive genetic 
testing. Given that there is no professional guidance in respect of carrier testing 
in New Zealand, presumably the same principles as those espoused in the HGSA 
guidelines on Predictive	Testing	would apply. 
Many of the other prominent position statements and guidelines from professional 
groups in other jurisdictions also provide that minors can make their own decisions 
about genetic testing provided that they meet varying standards of competence, 
understanding and voluntariness. Arbitrary age restrictions are rarely set down. 
1.3.3  Attitudes and professional practice relating to genetic testing of minors
The evidence and issues outlined earlier raise significant concerns for the appropriate 
handling of genetic testing requests for minors, whether on behalf of those who 
cannot give a valid consent, or by competent minors themselves. 
The lack of knowledge amongst New Zealand GPs of genetics and of avenues 
for seeking further advice on genetic testing obviously has implications for the 
appropriateness of the ordering of genetic tests, and for informed consent processes.2 
The NHC report strongly emphasised the need for GPs to discuss with or refer most 
genetic testing (particularly predictive and susceptibility testing) to a genetics service, 
because of their lack of experience and specialist knowledge of genetic testing. This 
is particularly important in the case of genetic testing requests for minors, given the 
special care required during the informed consent process. 
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The results of the research undertaken with New Zealand GPs are of particular 
concern in light of the international evidence revealing greater willingness on the 
part of primary-care health-care professionals to provide predictive genetic tests and 
carrier tests for minors. Without further investigation and evidence it is difficult to 
gauge whether our primary health care professionals would be equally enthusiastic 
about genetic testing of minors. However, there is evidence that GPs are more likely 
to emphasise the benefits of susceptibility testing for BRCA mutations than the 
possible psychological harms.3 There is also evidence that New Zealand’s GPs are 
generally positive about getting involved in genetic testing decisions, if they are well-
resourced to do so.
More positively, the GPs surveyed appear to recognise their own limitations in terms 
of understanding clinical genetics, and currently seem to be more likely to refer 
patients to a genetics services than order genetic tests themselves. 
It is vital that GPs and other health professionals know more about genetic testing and 
genetics services in New Zealand so that they can better facilitate informed consent; 
they recognise and acknowledge any limitations in their expertise, particularly as 
they will influence their patients when they discuss testing possibilities; they know 
when to refer patients for genetic testing; and they can offer some degree of genetic 
counselling, if required. 
A lack of genetic expertise and genetic counselling is also of concern for competent 
minors seeking genetic tests because one of the important benefits of genetic testing 
upon a minor’s request is the chance for interaction with a knowledgeable health 
professional, rather than having to rely upon genetic information given by family 
members.
Whilst there is some professional guidance on genetic testing of minors from the 
HGSA, and laboratory protocols on predictive testing generally, these do not appear 
to be well-publicised or formalised. Pathologists involved in genetic testing would 
be aware of the HGSA guidance on genetic testing of minors and their oversight of 
genetic testing requests provides a useful filter for weeding out inappropriate testing 
of minors (and others); however the ad	hoc basis upon which it is currently organised 
does not promote accountability. The lack of a more formal structure and process 
for genetic testing requests also means that GPs and other health professionals 
may be making inappropriate requests for testing that are (rightly) not actioned by 
pathologists, resulting in a waste of time and resources, and increased expectations 
and stress for at-risk families and children. 
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.  Benefits and harms involved in genetic testing of minors
1.4.1  Competent minors
Empirical evidence of benefits and harms of genetic testing is very limited. However, 
the most recent and extensive evidence points towards testing having the potential to 
be more beneficial than harmful for competent minors who request testing.
For some of the purported benefits and harms there is no evidence, or only 
inadequate evidence. Other purported harms do not sufficiently justify a conclusion 
against genetic testing of competent minors upon request, because they relate equally 
to other health-care contexts; they relate to adults also; or they can be mitigated or 
resolved via alternative methods to blanket prohibition. 
Many of the potential harms should not be an issue if correct procedures are adhered 
to, particularly around clear procedures and timeframes for counselling and testing; 
and clear rules and procedures for method, timing and persons to whom disclosure 
of results will be made. 
Some of the benefits of genetic testing are knowable a	priori, and at the time of writing 
there appears to be more convincing evidence for the benefits that arise from genetic 
testing than harms, particularly for competent minors. Evidence of harms is limited 
and harms specifically or more particularly related to competent minors are even 
more speculative. Additionally, some of the harms projected as a result of genetic 
testing can already be seen in minors living at-risk for a heritable genetic mutation. 
There is a great need for thorough genetic counselling before a decision is made about 
whether to undergo genetic testing. The benefits and harms of testing frequently 
appear dependent on the individual’s life story and relationships prior to testing; 
and  plans and level of support after testing (particularly where other harms relating 
to information management have been appropriately managed). Evidence from 
predictive testing for HD in adults shows that predictors of negative psychological 






Given the absence of convincing evidence that genetic testing is too harmful for 
minors generally, competent minors should not be denied the opportunity to 






the	 child’s	 right	 for	autonomy,	 confidentiality,	and	privacy,	must	be	primarily	
considered	when	developing	formal	guidelines.6	
1.4.2  Minors lacking understanding to give their own consent
The same limited body of evidence exists against which to judge both the effects of 
genetic testing of minors who can give their own consent, and testing of those who 
cannot. However, two very different conclusions have been reached, because of the 
different consequences of testing each group.
Testing upon a competent minor’s request may be beneficial and even enhance that 
minor’s competence and autonomy. However, when testing a child who cannot 
give informed consent is not clinically indicated there is reason to suspect that 
psychological or social harms may arise; whether from early knowledge that one will 
inherit an untreatable disorder; because one has had no say in whether or not to be 
tested; because parents may treat their child differently, to the child’s detriment; or 
because of an inability to prevent parental dissemination of one’s genetic information. 
Genetic testing for non-medical reasons, as a rule, should not be performed on 
minors who cannot give their own informed consent to testing because of the lack of 
evidence of the effects of genetic testing of minors; the fact that many adults choose 
not to discover their own genetic risk status; and the threats to a child’s autonomy and 
confidentiality. Where there are no medical benefits to genetic testing, such testing 
should be delayed until the minor can give his or her own consent to testing. 
Predictive genetic testing for an early onset condition for which no beneficial 
medical interventions exist raises fewer concerns than testing for a similar late-onset 
condition. The same potential benefits exist, but not the same harms – because the 
danger to the minor’s future autonomy, to make a decision and potentially exercise 
the right not to know the information, is not as salient. Thus, the putative benefits 
of such testing (relieving anxiety, preparing for onset etc.) may be weighted more 
heavily in this context regardless of whether or not the disorder is treatable. 
However, given that there are no clinical benefits to such testing, and that there may 
be some harms (changed parental expectations and treatment of child etc.) parental 
requests for such testing should still be treated very cautiously. 
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.  legal frameworks for medical decision-making – issues raised by genetic   
 testing
1.5.1  Minors who cannot give a valid consent
In determining whether a child not able to understand the nature of genetic testing 
should be tested the legal test should focus on the benefit(s) that will accrue to the 
particular child from the testing. Genetic testing of young children who cannot give 
their own legally effective informed consent should only be carried out where it 
will prevent onset, alleviate symptoms or provide a cure. This rules out carrier and 
predictive testing for conditions which do not manifest themselves in childhood and 
conditions for which there is no medical treatment available.
1.5.2  Competent minors
Self-referral for genetic testing by minors does occur, albeit rarely. The two major 
objections to permitting minors to consent to genetic testing are that genetic testing 
is too harmful for minors; and genetic testing, and its implications, are so complex 
that minors could not be competent to give valid informed consent to testing.
There is no explicit regulation or policy relating to genetic testing of minors in New 
Zealand. In our view competent minors can consent and also refuse consent to all 
kinds of genetic testing, pursuant to section 36(1) of the Care of Children Act 2004 
(if they are of or over the age of sixteen years), Gillick	as applied in New Zealand, the 
Code of Health and Disability Services Consumers’ Rights 1996, The United Nations 
Convention on the Rights of the Child and the New Zealand Bill of Rights Act 1990 
also support this view. 
Once a minor is deemed competent (statutorily, or in light of her maturity and 
understanding) then harms and benefits become largely irrelevant (except to the 
extent that any health professional can refuse to provide services that have no medical 
benefit), and competent minors’ requests for testing should be treated in the same 
manner as requests by adults. However, if the reference to benefit in section 36(1) 
of the COCA 2004 is taken to mean that sixteen and seventeen-year-old minors can 
only consent to procedures that are intended to benefit them, they can still consent 
to genetic testing, whether or not treatment is available for the disorder for which 
they are seeking treatment, because there are benefits in knowing one’s future genetic 
health status.
At the time of writing there appears to be more convincing evidence for the benefits 
that arise from genetic testing (some of which are knowable a	 priori), than the 
purported harms, in respect of competent minors who request genetic testing.

There is a distinct paucity of evidence of actual harm arising from genetic testing 
of minors, and harms specifically related to competent minors are even more 
speculative. Additionally, some of the projected harms can already be seen in minors 
living ‘at risk’ for a heritable genetic mutation: harm can arise from not acceding to a 
competent minor’s request for genetic testing. 
Thorough genetic counselling, and an individual	 assessment of the minor’s 
competence to consent is vital before a minor makes a decision about whether to 
undergo predictive genetic testing or carrier testing. The benefits and harms of testing 
frequently appear to be dependent on the individual’s life story and relationships 
prior to testing; and plans and level of support available after testing. 
Some have argued that consenting to genetic testing requires a higher degree of 
competence than consent to other kinds of medical procedures, because of the ethical, 
psychological and social issues. However, genetic testing raises the same issues in 
terms of legal competence to give informed consent, as other medical procedures: 
consent must be given voluntarily, on an informed basis, by a competent person. 
Genetic information may be more complex, and contain more uncertainties or 
probabilities than other medical information. However, this provides a challenge for 
health professionals to fulfil their obligations under the Code and give competent 
minors the requisite information in such a way that they can understand it and give 
legally effective informed consent. There is evidence that adequately educated and 
informed minors can understand the necessary genetic information to give informed 
consent to genetic testing.
The legal criteria for assessing competence remain the same in the context of genetic 
testing: the person must understand the purpose of the procedure, the nature of 
the procedure and the consequences and implications. Notably, professional position 
statements on genetic testing of minors do not appear to imply that there are different 
criteria for assessing competence for purposes of genetic testing. 
Larcher’s model for assessing competence, coupled with Binedell’s questions to 
consider when exploring whether minors understand the purpose, nature and 
consequences and implications of genetic testing, may provide appropriate tools 
with which genetic counsellors (and others) can assess the competence of minors to 
give legally effective informed consent in the clinical genetics setting. 






.  Disclosure, confidentiality and privacy 
1.6.1  Disclosure of genetic risk to the minor
Parents may be under a moral duty to inform their children of heritable genetic 
mutations when: their children are adults; there is no likelihood of serious harm 
or risk to life or, notwithstanding, there are no useful interventions available; or 
when the condition is late onset. However there do not appear to be any legally 
recognisable duties requiring this type of disclosure (except where it is necessary to 
prevent permanent injury to the health of or to save the life of a minor under the age 
of sixteen years, section 152 Crimes Act 1961). 
The available evidence suggests that people tend to be in favour of informing their 
children of their genetic risks, and of informing them themselves, rather than via a 
health professional. It is, however, obviously a delicate and often difficult task, and 
the ages vary at which parents consider disclosure appropriate.
Health professionals generally cannot inform a minor about a heritable genetic 
condition in the family without the permission of the person from whom the health 
information was gleaned (particularly without an explicit request for the information 
from an at-risk minor). And yet parents are under no legal duty to inform their 
children of heritable genetic condition within their families for which they may be 
at risk.
Whatever parents and guardians decide about informing their children of their 
genetic risks, the matter is currently unregulated. Parents can be advised by a health 
professional about an appropriate age and way in which to inform their children but 
families will make these decisions for themselves. 
1.6.2  Disclosure of genetic test result to the minor
Health professionals can encourage parents to inform their children of their genetic 
test result, and where they refuse to do so health professionals will be subject to fewer 
constraints in informing the minor themselves (compared to those outlined earlier 
in respect of informing minors of increased risk based solely on familial genetic 
information).
A minor who is seeking access to genetic test results, rather than information about 
risk status on the basis of other family members’ health information, does not 
provoke the same the concerns for a health professional in respect of the privacy 
and confidentiality of others. However, as with disclosing familial genetic risk, there 
currently exists no	legal	duty	to	warn a minor regarding genetic test results. 
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Minors might be refused access to their genetic tests results pursuant to sections 
29(1)(c) and 29(1)(d) of the Privacy Act 1993 if the information were considered 
prejudicial to their interests, or physical or mental health. Given the complexities, 
deciding whether or not to disclose a minor’s genetic test result will require a very 
careful case-by-case approach. Genetic counselling will be necessary if minors are to 
be told that they carry a genetic mutation, and may be necessary regardless of the test 
result. If minors are aware that they have been tested for a heritable genetic mutation 
but are denied access to the test results both by their parents and health professionals 
(who all presumably know the results), one can only guess the psychological harm 
that could ensue. The concerns raised by disclosing the information, coupled with the 
concerns raised by refusing to disclose the information, support the argument that 
carrier or predictive genetic testing that is not clinically indicated should generally be 
restricted to those who competently request it, and generally not be permitted on the 
basis of parental consent alone. 
Parents do not appear to be legally obliged to inform their children of their own 
genetic test results: they are not covered by the Privacy Act 1993 or the HIPC or 
bound by any duties under the Crimes Act to inform their children of genetic test 
results, except where these may seriously threaten their health or lives (section 152, 
Crimes Act 1961).
1.6.3  Should there be a duty to disclose genetic risks to minors?
Public health and policy considerations might favour some form of duty to inform 
children of the existence of their own genetic test results over a duty to inform children 
about their genetic origins. In regard to genetic test results, the information to be 
disclosed belongs solely to the child tested: it does not concern the identification of 
someone else who may not want to be identified, as may information about genetic 
origins. Additionally, in many cases the genetic test result information will have been 
identified as having potentially health or life-threatening consequences if undisclosed. 
A register should be established to facilitate disclosure to persons who have reached 
the age of sixteen or eighteen (or earlier if they are competent and personally 
seek access to the information) of the fact that they underwent genetic testing as 
children. The information initially disclosed may inform the minor either that the 
minor underwent predictive or carrier testing as a child, or that some information 
is available about genetic risk status (if disclosing the fact of having been tested is 
considered to be too much unsought information for the first contact). 
This notification could be achieved in a similar fashion as for relatives who were 
notified about genetic testing for a familial disorder by the South Australian Familial 
Cancer Service (FCS).
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We consider a genetic test results register established for this purpose to be the 
appropriate approach to ensuring that people who undergo testing as children are 
informed of the fact, because:
• It would encourage parents and health professionals to disclose test results to 
children – as the fact of testing will be disclosed to them anyway;
• It gives the person tested as a child the choice whether or not to learn the 
information (assuming that he or she has not already been told); and
• It avoids the difficulties of imposing a new duty which may have unwieldy and 
undesirable consequences in terms of monitoring, enforcement and sanctions.
Genetic counselling services would be required to assist any minors contacted 
through this process in deciding whether or not to access their test result, and to 
support them whatever their choice. 
And, of course, the privacy of any such register and the information it contained 
would have to be strictly maintained.
We do not argue that a similar register be established to keep track of information 
about minors who are simply at increased risk for a heritable disorder but who have 
not been tested themselves. The issue of disclosure of familial genetic risk cannot 
be resolved as neatly because it relates to all family relationships, and not just those 
between parents and their children. The implications are much wider than can be 
considered here. However, it is desirable that families do inform their children of 
familial genetic risks and let them make up their own minds about how to use the 
information (if genetic testing is not clinically indicated during childhood); health 
professionals should encourage parents to do this. 
1.6.4  Should there be legal restrictions to prohibit parents from disclosing their   
 children’s health information?
As with imposing a duty on parents to disclose genetic test results to minors, we 
are concerned about the enforceability, monitoring and any punitive mechanisms 
attached to such a duty. However, a duty of confidentiality may be more readily 
enforced than a duty to disclose information to minors: the agency charged with 
enforcing the duty can take a reactive role once unwarranted disclosure has been 
made, rather than the more proactive and interventionist role required in order to 
police disclosure to the minor. 
The child’s privacy interests need to be weighed against the interests served by allowing 
parents to disclose their child’s genetic test results to certain people or agencies (e.g. 
school or caregivers so that they can be alert for early symptoms) and the parents’ 
rights to freedom of expression (section 14, New Zealand Bill of Rights Act 1990). 
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The lack of a parental duty of confidentiality and the difficulties raised by the 
imposition of such a duty provide another strong argument against genetic testing of 
children upon the basis of parental consent.
A general rule against genetic testing of children coupled with rigorous genetic 
counselling emphasising the need to inform the child of the genetic test result, and 
the need to keep the information private, may be the most effective way to safeguard 
the child’s overall interests: rather than permitting testing and trying to police the 
sequelae. 
1.6.5  Competent minors and privacy
Competent minors who have had genetic testing on the basis of their own informed 
consent are entitled to the same rigorous protection of their privacy and confidentially 
as are adults. This is particularly important in the genetic testing context because of 
the greater family interest in learning the information, and the current lack of any 
legal duty on parents or others who learn of their results to keep such information 
private. 
2  comPetent minors requesting genetic tests –    
 imPlications For ProviDers
Where does the above assessment leave the health professional faced with a minor 
requesting a genetic test? 
Health professionals can act upon the informed consent of a minor aged sixteen or 
over in the same way that they would act upon an adult’s request. 
Genetic counselling would be required before any predictive testing was undertaken, 
and presumably also before a minor underwent carrier testing. The competence of 
a minor under the age of sixteen to make the decision should be assessed during the 
course of genetic counselling, and the request respected if the minor is competent to 
make the decision.
But what about when various parties to the decision disagree about testing? Consent 
issues with respect to competent minors are intricately connected with the issue of 
health professionals’ safety and liability in terms of acting on informed consent. 
Whether or not a minor’s consent or refusal is adhered to often seems to turn upon 
who agrees or disagrees with the decision made. In New Zealand, as in the United 
Kingdom, cases where a minor (and/or her parents) refuse treatment that health 
professionals think is in the minor’s best interests seem to be the most controversial 
and litigious. 
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It is instructive to re-examine the possible scenarios. 
•	 A minor might seek genetic testing with the support of her parents or legal 
guardians. 
When a minor under the age of sixteen is seeking a procedure or treatment with 
the support of parents or legal guardians, health professionals should nonetheless 
encourage the exercise of autonomy by helping the minor to participate in or make 
the decision, giving the minor the opportunity to take responsibility for health 
decisions.8 Participating in decision-making, and making decisions, enhances a 
minor’s confidence, autonomy and decision-making abilities.
However, minors should not be forced to take responsibility for the decision, when 
they do not want to. It will be up to the minor and family to decide upon the final 
arbiter, and to establish who will give legally effective consent to the testing. Where 
the minor is competent to give consent the health professional can safely rely upon 
the informed consent of the minor or guardians. 
However, during counselling it must be recognised that ‘a child may not be able 
to exercise free choice in the face of strong parental opinions or parental discord’.9 
Health professionals must be alert to the possibility that a minor has been coerced or 
subdued into accepting the parents’ wishes, and is unaware of the decision-making 
process. The possibility of the minor being able to make the decision should be raised 
where a minor ‘appears to exhibit a level of maturity that warrants inquiry’.10
•	 A minor might seek genetic testing alone, or with a friend or an adult who is not 
entitled to give proxy consent to medical procedures on the minor’s behalf. The 
minor’s parents or guardians might be unaware or disinterested that their child 
is seeking genetic testing. 
The HGSA policy on Presymptomatic	and	Predictive	Testing	of	Children recommends 
that discussion between parents and children be encouraged when assessing the 
competence of a minor. 
Given the familial nature of genetic information, and the potentially serious 
consequences of undergoing a predictive genetic test in particular, the family context 
is always important when assessing minors’ requests for testing. The minor’s reasons 
for seeking a genetic test alone will need to be thoroughly explored. For example, a 
minor might be seeking a genetic test alone after discovering a 25 per cent risk for 
the HD mutation, because of a maternal family history, with the mother refusing 
to discover her own risk status. If the minor tests positive for the HD mutation, 
her mother will develop HD. The HGSA general policy on Presymptomatic	 and	
Predictive	Testing	for	Genetic	Disorders states that, although this type of issue should 
not override an individual’s access to testing, it should be considered and discussed 
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in pre-test counselling. The policy recommends involving the parent at 50 per cent 
risk in counselling, where possible, and discussing whether and how other family 
members should be approached after test results are known.
Where parents do not know that a young person has sought medical advice, and 
the young person does not want the parents involved, then the health professional 
can be in a difficult position. There are very limited exceptions as to when a health 
professional may imperil the doctor–patient relationship and breach confidentiality. 
Most of these exceptions revolve around safety, whether of the patient or others. Thus 
if a health professional did not have any reason to suspect that the young person or 
others were in danger, by the retention of confidentiality, he or she could generally 
not discuss the matter with the young person’s parents (see discussion on privacy 
earlier). However, where safe and reasonable, health professionals should encourage 
young people to discuss their health concerns with a parent or guardian.
It has been argued that




Thus health professionals should attempt to convince the minor to communicate 
with the parents or guardians or other supportive adults about the decision. The 
evidence discussed earlier shows that there are potential harms involved in genetic 
testing, whether the results are mutation positive or mutation negative, and the young 
person will need a support system in place during and after the testing process.
•	 A minor might seek genetic testing against the wishes of her parents or 
guardian.
The	 key	 to	 managing	 this	 situation	 will	 be	 providing	 the	 child/young	 person	
and	their	parents	with	sufficient	opportunity	to	work	their	differences	through,	
separately	or	 together,	depending	on	 the	circumstances	of	 the	case.	The	health	
service	 involved	may	be	able	 to	assist	by	providing	 social	work,	 counselling	or	
cultural	 support	and	assistance	 to	 family	members.	 In	 some	 situations	 it	may	
be	 advisable	 to	 seek	 an	 independent	 ‘advocate’	 to	 represent	 the	 views	 and/or	
interests	 of	 the	 child/young	person.	…	Only	when	matters	 cannot	 be	 resolved	
informally	should	it	be	necessary	to	seek	legal	advice.12	
When a minor is of or over the age of sixteen then his or her consent or refusal 
to consent must be respected. When a minor is Gillick	competent then his or her 







It	 is	 tempting	 to	 give	 a	 young	 person’s	 views	 more	 weight	 when	 these	 differ	
from	 those	 of	his	 or	her	parents,	 because	 such	 independence	of	 views	 suggests	
that	 the	young	person	 is	more	 likely	 to	be	autonomous.	However	 the	 strength	
of	this	conclusion	will	depend	very	much	on	the	particular	nature	of	the	family	
relationships.13	
What about a case where a health professional is reluctant to act upon a competent 
minor’s consent alone, when a minor is under sixteen and the parents are against 
the genetic testing? Wertz, Fanos and Reilly argue that testing should be postponed 
‘until majority, on the grounds that the parents may be aware that the minor is not 
sufficiently mature’.14 However in cases of conflict it is important for the professional 
to determine why parties disagree about testing. Given the familial nature of genetic 
information, it is important to establish that the parents are not simply against their 
child being tested because the results may reveal unwanted information about other 
family members. 
Pursuant to section 27 of the COCA 2004 a young person who wanted a carrier 
or predictive test to which the parents refused to consent could apply to the Court 
(or have someone else apply on the young person’s behalf) for some other person 
(presumably a person who supported the testing) to be appointed as guardian for the 
purposes of making medical decisions.15
The Court may appoint a person as a guardian of a minor, either in addition to 
any other guardian or as sole guardian, on application by any person or by its 
own initiative, for a specific purpose or generally, and for a specified time or not 
(section 27). A Court-appointed guardian would generally have all of the rights 
and responsibilities of a standard guardian, including the right to consent or refuse 
to consent to medical treatment on behalf of the minor. Indeed, as the Court has 
the power to appoint a guardian for a specific purpose and for a specific time, the 
guardian might be appointed for just such a purpose. 
Alternatively, the young person could apply to be placed under the guardianship of 
the Court (pursuant to sections 31 and 34 of the COCA 2004). Presumably a minor 
would only be advised to seek to be placed under the guardianship of the Court if 
there were a reasonable probability that the Court would agree with the minor’s view 
on having a genetic test. 
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An eligible person (a category which includes a range of relatives, the minor herself 
and any other person granted leave by the Court) may apply to the Court, pursuant 
to section 31, for an order placing a minor (who is not married, in a civil union or 
in a de facto relationship) under the Court’s guardianship.16 Such applications, when 
granted,17 give the Court guardianship rights and powers.18 The Court would thus 
be the minor’s guardian for the purposes of giving consent or refusal to consent 
to medical procedures or treatment. When the Court is a guardian of a minor its 
guardianship rights surpass those of any other person.19 
A young person could also seek to invoke the (High) Court’s inherent protective 
parens	patriae jurisdiction20 and be made a ward of the Court in that manner.
If another guardian were appointed by the Court, and gave consent to a genetic test 
being performed on a minor, the health professional could then be satisfied that she or 
he was proceeding on the basis of the legally effective consent of the minor’s guardian 
(if he or she had previously been reluctant to act on the consent of the minor alone). 
However, we reiterate that if a minor under the age of sixteen is competent then a 
health professional can test on the basis of that minor’s legally effective consent. 
•	 A minor might be refusing genetic testing that the parents or guardians want the 
minor to undergo.
A competent minor’s refusal to have a carrier test or a predictive test which is not clinically 
indicated must always be respected. There would be no clinical harm for the competent 
minor in respecting the refusal to consent to such a test. Given the controversy over 
predictive or carrier testing of minors, it is unlikely that a health professional would 
accept a parent’s consent to testing over a competent minor’s refusal. 
A competent minor who is refusing genetic testing that is clinically indicated (for 
example, for the FAP mutation) should also have her refusal to consent to testing 
respected, as an adult’s refusal would be. 
2.  conflict with the health professional
We have discussed the options and actions available where a minor and parents 
disagree as to whether the minor should undergo a genetic test. Minors and/or their 
parents may also disagree with health professionals about whether a minor should 
have a genetic test. 
A health professional may not want to provide genetic testing when it is not clinically 
indicated, believing that testing would not be in the minor’s best interests. 
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Disagreements between minors and/or parents and health professionals:
may	be	 the	 result	of	 failures	of	 communication	or	understanding,	 rather	 than	
basic	disagreement	about	what	is	best	in	the	situation.	It	is	of	course	paramount	
that	professionals	make	every	effort	to	avoid	and	remedy	any	miscommunication	




It is important that health professionals seek to understand why a minor and/or 
parent disagrees with his or her advice about whether or not to undergo genetic 
testing. This will (hopefully) usually be canvassed thoroughly in genetic counselling. 
However, as the NZPS report notes, there may simply be irresolvable differences 
about the value of genetic testing for the particular minor. 
There is a concern that when a seemingly Gillick	competent minor disagrees with 
a health professional’s medical advice the minor will ipso	 facto be considered 
incompetent. As discussed earlier, in the section on ‘Concerns with criteria for 
competence’, this would be an injustice as the wisdom of a decision or its congruence 
with medical opinion is not a criterion for judging competence in adults.
Rejection	of	professionally	recommended	treatment	by	a	child	under	16	should	
not	 automatically	 be	 taken	 as	 evidence	 of	 lack	 of	 competence	 to	 decide	 their	
own	health-care.	The	more	serious	the	consequences	of	rejecting	the	treatment,	
the	 greater	 care	must	be	 taken	 in	ascertaining	 the	 level	 of	understanding	and	
decision-making	competence	of	the	child.22
The NZPS discussion document on Disagreements	Between	Professionals	and	Families	
About	Health-care	for	Children	and	Young	Persons states that:





However, ultimately, health professionals cannot be forced to act against their 
clinical judgment (In	Re	 J	 (A	minor)	wardship:	medical	 treatment [1992] 4 All ER 
614), so when a young person (or any individual) is seeking treatment that a health 
professional considers unwise the minor may be referred elsewhere. In this regard, 
right 6(3)(c) of the Code states that every consumer has the right to honest and 
accurate answers to questions relating to services, including questions about how to 
obtain an opinion from another provider.
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It has been argued that health practitioners could be held liable in negligence if they 
failed to test a competent minor upon request and the minor subsequently bore a child 
affected with the disorder for which she had wanted to be tested.24 Putting aside any 
difficulties in proving the casual nexus, and that the child would not have been born if 
the competent minor had been tested as requested, New Zealand health professionals 
cannot be proceeded against for compensatory damages because of New Zealand’s 
accident compensation scheme. They can be sued for exemplary damages; however, 
the plaintiff needs to prove that the health professional displayed ‘truly outrageous 
conduct which cannot be adequately punished in any other way’.25 This threshold is 
unlikely to be met by a health professional who refuses to test a competent minor 
for carrier status or for a late-onset disorder, given that the predominant discourse 
suggests that minors should not be tested. 
  regulatory oPtions
Models and analyses of genetic testing have mostly been published in other countries; 
New Zealand needs to formally examine social and ethical issues of genetics and 
genetic testing within the New Zealand context.26
The concerns raised by practice and attitudes towards genetic testing of minors, the 
lack of knowledge of many health-care professionals about genetics (and consequently 
some of the ethical, social and legal implications of genetic testing of minors) and the 
intricacies of the national genetics services context indicate that New Zealand-specific 
guidance is required in respect of requests for genetic testing of minors in various 
scenarios. What form should this guidance take and how directive should it be?
 
.  status quo
3.1.1  Current medico-legal framework
Essentially the current legal context permits parents to consent to medical procedures 
and treatments on behalf of their children. If there is some dispute and proceedings 
are taken under the COCA 2004 or the Children, Young Persons and Their Families 
Act 1989, or any other proceedings are taken relating to the guardianship or care of 
the child, the welfare and best interests of the child are paramount. Best interests are 
to be interpreted widely. 
The current legal framework for medical decision-making in respect of incompetent 
children will not necessarily afford children the protection required in the context of 
predictive and carrier testing. Currently parents can consent to this kind of testing on 
behalf of their children, if they can find a health professional to perform the testing. 
We recommend that a ‘substituted judgement’ test which emphasises benefit for the 
child is a more appropriate approach then the ‘best interests’ approach which allows 
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factors extraneous to the child to be taken into account. We believe that genetic testing 
of young children should only be carried out when it will prevent onset, alleviate 
symptoms or provide a cure. It should not be carried out for conditions which do 
not manifest themselves in childhood and conditions for which there is no medical 
treatment available.
The current legal framework is largely appropriate as it pertains to competent minors 
and medical decision-making: the same general approach should govern requests 
by competent minors for genetic testing. However, the scope and the nuances of the 
existing framework may need to be clarified for health professionals to avoid as far 
as possible the danger that they will be practising defensively and paternalistically in 
respect of genetic testing requests from competent minors rather than with the more 







to	 shop	 around,	 their	 access	 to	 services	 dependent	 on	 the	 views	 of	 individual	
clinicians.27
The limited variety of genetic testing services in New Zealand makes the ability 
to shop around for a clinician who will provide services even more difficult. Such 
shopping around is not possible within New Zealand.
3.1.2  HGSA Guidelines
The HGSA Guidelines are not legally binding but they do give clinicians pause 
to consider and guidance on the ethical and social issues raised by genetic testing 
of minors. The Guidelines do of course hold some professional sway, and health 
professionals who act against the Guidelines must be prepared to justify the breach 
if required. 
The HGSA Guidelines do not only apply to geneticists; they apply to anyone working 
in the field of genetics. They are thus equally applicable to GPs and other primary and 
secondary health-care practitioners who come into contact with genetic medicine.
However, the HGSA Guidelines do not appear to enjoy a high profile outside of the 
clinical genetics and pathology context.
Additionally, there are no HGSA guidelines on carrier testing of minors. Presumably, 
in practice, the same rationale and principles as those in the HGSA predictive testing 
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guidelines would be applied: general caution against testing of minors who cannot 
give informed consent where there is no medical benefit (which will most often 
be the case in the context of carrier testing), and permitting competent minors to 
consent to carrier testing. 
We do not advocate a blanket prohibition on testing. There are always exceptional 
cases where discretion is needed. For example, whilst testing under eighteen-year-
olds for HD is very strictly advised against, there may be an argument for such testing 
when a thirteen or fourteen-year-old girl is pregnant and she is at 50 per cent risk of 
developing HD. She should have the option to be tested for HD in order to decide 
whether she wants prenatal diagnosis for HD. 
3.1.3  Laboratory protocols
Pathologists’ oversight of genetic testing requests provides a useful filter for weeding 
out inappropriate testing of minors (and others); however the ad	 hoc basis upon 
which it is currently organised does not promote accountability. The lack of a more 
formal structure and process for genetic testing requests also means that GPs and 
other health professionals may be making inappropriate requests for testing that are 
(rightly) not actioned by pathologists, resulting in a waste of time and resources, and 
increased expectations and stress for at-risk families and children. 
.2  legislation
Legislation, whether by way of statute or regulation, would be an unusual approach 
to genetic testing of minors. Although there may be others, Norway is the only 
country, that we have discovered, which explicitly legislates against genetic testing 
of minors under the age of sixteen for non-medical reasons. We do not advocate a 
blanket legislative prohibition on genetic testing of minors. We do advocate that the 
best interests test be replaced by a substituted judgment test when decisions are made 
about children who lack the understanding to make the decision themselves.
Public health regulation requiring genetic counselling for predictive genetic testing 
is appropriate.28 Parents who request predictive testing of their children should 
undergo mandatory genetic counselling as to the implications. Compulsory genetic 
counselling of minors under the age of sixteen seeking genetic testing is justified 
because minors comprise a more vulnerable group and they would also require a 
competence assessment which could be undertaken within the genetic counselling 
session(s). A genetic counselling requirement could be incorporated into the Code of 
Health and Disability Services Consumers’ Rights (e.g. see right 7(6) which requires 
written consent for participation in research or experimental procedures). 
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.  education
One of the greatest needs in this area is for more education among primary health-
care professionals and specialists about genetics and the ethical issues involved, 
including the existing HGSA Guidelines. Otherwise, there is a risk that they might 
be referring pre-symptomatic children for genetic tests without the health-care 
professionals themselves or the families and children being adequately aware of the 
implications and risks involved. (As mentioned earlier, inappropriate requests for 
genetic tests may get picked up by the pathologists. However, inappropriate ordering 
of genetic tests wastes time and resources and may increase stress and engender 
unrealistic expectations.) 
The 1995 Report Priorities	 for	 Genetic	 Services	 in	 New	 Zealand considered public 
education and continuing education of health professionals to be a high priority. 
The report recommended resourcing of a readily accessible central facility to supply 
both scientific and lay information nationwide, and the offering of seminars and 
educational updates to health professionals and support groups by genetics services 
staff. They also recommended continuing the process of updating factsheets.29 
The NHC also recommended, in the 2003 Report Molecular	Genetic	Testing	in	New	
Zealand,	that GPs, specialists and medical students have increased access to genetic 
education (which would apparently feed into any review of the medical curricula), 
and that ‘ways of making information about genetics more accessible to the public 
be investigated, including information about the limitations of genetic testing’, 
particularly in relation to predictive testing. They suggested that the public needed 
access to sources of information other than through medical practitioners. This is a 
prudent recommendation given the influence that medical practitioners’ attitudes 
may have on their patients.30 
A new Primary Care Genetics Society has recently been established in the United 
Kingdom:
…	to	support	primary	care	professionals	(PCPs)	as	they	find	themselves	dealing	
with	 an	 ever	 demanding	 public	 who	 are	 continually	 being	 fed	 information	
about	 genetics	 from	 various	 sources	 including	 the	 internet	 and	 lay	 media.	 …	
and	to	support	and	facilitate	the	educational	needs	of	PCPs	to	help	translate	the	
continuing	advances	in	clinical	genetics	into	practice.31	
The Primary Care Genetics Society is partnered with the Genetic Interests Group 
and other community interest and support organisations. This is a model that may 
prove useful for educating and supporting New Zealand primary-care practitioners 
and patients in issues relating to genetic testing. 
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However, while increased education is certainly desirable, on its own it will not 
necessarily result in consistency and transparency of decision-making in this area. 
.  national guidelines or code of practice regarding genetic testing for all health  
 professionals
Since as early as 199532 there have been concerns raised about the management and 
structure of genetic services in New Zealand. The 1995 report Priorities	for	Genetic	
Services	in	New	Zealand recommended that clinical genetic services be nationally co-
ordinated and regionally provided. The authors recommended a structure of expert 
centres with outreach provision to smaller centres.33 They further recommended 
that co-ordination of access to genetic tests be through a geneticist or other tertiary 
specialist, to help ensure that test results were interpreted appropriately. (This 
recommendation was echoed in the 2003 Report Molecular	Genetic	Testing	in	New	
Zealand.) The authors endorsed the option of self-referral or enquiries or referral via 
a special disease association, particularly for cases where referral had been refused by 
health-care professionals.34 
While not all advice on genetic issues needed to come from a clinical geneticist, there 
needed to be good linkages between genetics services and primary, secondary, tertiary 
and laboratory services ‘to ensure that individuals receive accurate information and 
appropriate advice’.35 The Report also suggested that guidelines for referral to genetic 
services were essential to make the greatest use of a scarce resource. 
Regardless of whether the MOH implemented a nationally co-ordinated genetics 
services programme, the NHC noted in its 2003 Report (Molecular	Genetic	Testing	in	
New	Zealand)	that protocols were urgently required to assist practitioners to assess 
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The NHC contended that:
Protocol	development	would	address	the	inappropriate	ordering	of	genetic	tests	
and	lack	of	confidence	of	primary	healthcare	practitioners	to	provide	adequate	
information	 and	 to	 know	 when	 to	 refer.	 The	 committee	 would	 favour	 this	
approach	over	regulation.
The GPs involved in the surveys undertaken by the NHC group and Cameron et al. 
indicated that they wanted and needed more information about genetic conditions 
and genetic testing, by way of information sheets, or guidelines for referral for testing 
and managing mutation-positive patients etc. 
New Zealand needs consistent national policy for all health professionals who might 
come into contact with a request for genetic testing of a minor. GPs, paediatricians 
and other specialists may be involved with genetic testing without much knowledge 
of genetics or guidance from HGSA. The guidance on genetic testing of minors, 
whatever form it takes, needs to be widely disseminated to all registered health 
professionals and laboratories who might be faced with a request for genetic testing 
of a minor.
Some feel genetic testing should be handled by genetic specialists with GPs in a 
backup role, while others feel that GPs are in an ideal position to provide services, 
with adequate training and support.36 General Practitioners may know individual 
families and minors better than specialists: this could have advantages (related to 
knowledge of family history, issues and dynamics) and disadvantages (potentially 
reduced clinical objectivity). Regardless, all health professionals faced with genetic 
testing issues need to be aware of the ethical, legal and social implications raised, and 
have access to a readily available source of comprehensive and reliable information 
and guidance. Information from and about genetics services does not currently 
appear to be readily available to professionals or the wider community.37 
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  recommenDations
• Consistent national policy or guidelines are required for all health professionals 
who might come into contact with a request for genetic testing of a minor. 
The national policy or strategy and guidance should come from the MOH 
– perhaps from a special group established for this purpose. Consultation 
must be undertaken with the relevant health professionals (particularly clinical 
geneticists, paediatricians and GPs), to assess the types of roles each group is 
interested in and capable of fulfilling, and what would be required for each group. 
Consultation with special interest groups, such as the New Zealand Organisation 
for Rare Disorders, will also be necessary. Input from the Office of the Children’s 
Commissioner should be involved to ensure that the children’s rights and interests 
are represented. 
• The guidance on genetic testing of minors, whatever form it takes, needs to be 
widely disseminated to all registered health professionals and laboratories dealing 
with families and hereditary disorders. 
• The HGSA should consider drafting guidelines in respect of carrier testing of 
minors, or attach a protocol to the predictive testing policy stating that it applies 
to carrier testing, with the necessary amendments in terminology. 
• The following suggestions propose issues to be discussed and debated, and 
possibly included in any guidelines or code of practice: 
 • All requests for genetic testing of minors (other than diagnostic or where   
 there is a clear medical benefit to predictive testing) should go through   
 genetics services.
 • Mandatory genetic counselling of parents who make such requests,   
 including  discussion about privacy concerns (accords with HGSA   
 recommendations).
 • Mandatory genetic counselling of minors who request predictive or   
 carrier testing. Minors under the age of sixteen need to have their   
 competence assessed anyway, so this can be undertaken within the genetic  
 counselling context. 
 • Clear statement of the law regarding the ability of competent minors to   
 give informed consent, outlining, for example, the applicability of Gillick		 	
	 competence; the presumption of competence in the Code of Health   
 and Disability Services Consumers’ Rights; and article 12 of the United   
 Nations Convention on the Rights of the Child. 
 • Professional guidelines and practice in relation to competent minors’   
 requests for genetic tests should focus on assessing competence, and not   
 merely on cataloguing and gauging potential harms. 
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 • Statement that genetic testing decisions do not per	se	require a different   
 standard or method of measuring competence than other treatments and   
 procedures; guidelines for assessing competence generally, based on   
 Larcher’s model (as these seem to be somewhat lacking in the more general  
 medical context); and suggestions in respect of assessing competence for   
 genetic testing decisions in particular (based on Binedell’s model). Could   
 include referral to a child psychologist or psychiatrist who has some   
 experience in health or genetic counselling where competence is an issue.
 • Consent to predictive genetic testing or carrier testing should be in writing:  
 the competent minor’s consent (and the parents if they agree, so all   
 parties take ownership of the decision); or the parents’ consent on behalf   
 of a younger child. (This requirement could be incorporated into right   
 7(6) of the Code which states that, where informed consent to a health-care  
 procedure is required, it must be in writing if (a) The consumer is to   
 participate in any research; (b) The procedure is experimental; (c) The   
 consumer will be under general anaesthetic; or (d) There is a significant risk  
 of adverse effects on the consumer.) 
 • As stated earlier, some of the harms that are caused for competent minors  
 (and also adults) by genetic testing can be mitigated or resolved through   
 appropriate testing and counselling procedures: clear procedures and   
 timeframes for counselling and testing; and clear rules and procedures   
 for method, timing and persons to whom disclosure of results will be   
 made. A waiting period cannot be avoided, given the time that the testing   
 process takes. Interim anxiety or stress could be managed by:    
 foreknowledge of the timeframes involved in the testing process;    
 preparation for the waiting period; and a genetic counselling session   
 scheduled for the waiting period if desired or necessary. 
 • Similarly, the amount of genetic counselling provided, whether it be too   
 much or too little, is an issue frequently raised by those who have   
 undergone genetic testing. Dissatisfaction with the amount of genetic   
 counselling available is another issue that may equally affect adults.   
 There may be more satisfaction with the genetic counselling process if   
 the entire process, the timeframe and the rationale for each counselling   
 session are clearly explained to each person at the outset. There may be   
 room to add sessions where necessary or desirable. Consumers should be   
 told whether more or fewer counselling sessions are available upon request,  
 or where to go, what to do and whom to talk to if more counselling is   
 required. There may also be leeway to reduce the frequency or length of   
 sessions; although this may be less feasible because the level or amount   
 of counselling needs to keep pace with professionally determined minimum  
 requirements in order to obtain truly informed consent. 
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 •	 Establishment of a register of genetic test results for persons tested as   
 children on the basis of parental consent.
 Recommendations for further research: 
 –	 Frequency of current genetic testing and test requests in New Zealand, and  
 what GPs and specialists see as the best way of being informed about the   
 genetic services, information and protocols etc. available.
 –	 Mäori, Pacific Island and other ethnicities’ views in respect of genetic testing  
 of children, given that other cultures do not necessarily place the same   
 priority on individual autonomy as do Päkehä.
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